There's little doubt now -- study after study, in real life and in lab dishes, in the US and elsewhere -- that people's immunity starts to wane just months after they finish the two-dose series of ...
Pfizer vaccine fails to provide expected immunity for kids ages 2-5 in trials; Extra dose now tested
Vaccine maker Pfizer said Friday that trials of its vaccine in children ages 2 to 5 show that it did not provide the expected immunity in kids this age, and it is adding a third dose to the regimen.
Pfizer announced Thursday that a third shot of its COVID-19 vaccine raised omicron-fighting antibody by 36 times in children ages 5 to 11. Pfizer/BioNTech plans to request emergency use authorization ...
Pfizer presented data to investors showing that a third dose of its COVID-19 vaccine boosts immunity. The company believes everyone will need a... Pfizer Says A 3rd Dose Of Its COVID-19 Vaccine Boosts ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Pfizer Inc. is conducting a Phase 3 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results